{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:01:37Z","timestamp":1763535697010,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,23]],"date-time":"2020-02-23T00:00:00Z","timestamp":1582416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.amjmed.2019.11.015","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T22:32:02Z","timestamp":1584052322000},"page":"e280-e289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-7866","authenticated-orcid":false,"given":"Morten Rix","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asbj\u00f8rn","family":"Hr\u00f3bjartsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Videb\u00e6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-0107","authenticated-orcid":false,"given":"Zandra Nymand","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-5825","authenticated-orcid":false,"given":"Manan","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-0645","authenticated-orcid":false,"given":"Niels Herluf","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Broe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-5679","authenticated-orcid":false,"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-7187","authenticated-orcid":false,"given":"Per","family":"Damkier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.amjmed.2019.11.015_bib0001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0272989X9501500208","article-title":"Communicating the benefits of chronic preventive therapy does the format of efficacy data determine patients\u2019 acceptance of treatment?","volume":"15","author":"Hux","year":"1995","journal-title":"Med Decis Making"},{"issue":"10","key":"10.1016\/j.amjmed.2019.11.015_bib0002","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02599636","article-title":"The framing effect of relative and absolute risk","volume":"8","author":"Malenka","year":"1993","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.amjmed.2019.11.015_bib0003","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/S0149-2918(03)80318-1","article-title":"A randomized trial of laypersons\u2019 perception of the benefit of osteoporosis therapy: Number needed to treat versus postponement of hip fracture","volume":"25","author":"Christensen","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2019.11.015_bib0004","doi-asserted-by":"crossref","DOI":"10.1186\/s12875-015-0288-8","article-title":"Decisions on statin therapy by patients\u2019 opinions about survival gains: cross sectional survey of general practitioners","volume":"16","author":"Halvorsen","year":"2015","journal-title":"BMC Fam Pract"},{"issue":"16","key":"10.1016\/j.amjmed.2019.11.015_bib0005","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.amjmed.2019.11.015_bib0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjmed.2019.11.015_bib0007","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"year":"2008","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","key":"10.1016\/j.amjmed.2019.11.015_bib0008"},{"issue":"6","key":"10.1016\/j.amjmed.2019.11.015_bib0009","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199808063390606","article-title":"Gains in life expectancy from medical interventions\u2014standardizing data on outcomes","volume":"339","author":"Wright","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjmed.2019.11.015_bib0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/BF02599016","article-title":"The meaning of life expectancy","volume":"9","author":"Naimark","year":"1994","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.amjmed.2019.11.015_bib0011","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s11606-019-05024-4","article-title":"Postponement of death by statin use: a systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Hansen","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.amjmed.2019.11.015_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.amjmed.2019.11.015_bib0013","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.amjmed.2019.11.015_bib0014","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.amjmed.2019.11.015_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12872-017-0686-z","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.amjmed.2019.11.015_bib0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12872-016-0425-x","article-title":"Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis","volume":"16","author":"Berbenetz","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.amjmed.2019.11.015_bib0017","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4330\/wjc.v9.i2.182","article-title":"Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis","volume":"9","author":"Narayanan","year":"2017","journal-title":"World J Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2019.11.015_bib0018","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"27","key":"10.1016\/j.amjmed.2019.11.015_bib0019","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjmed.2019.11.015_bib0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/2047487312445425","article-title":"A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality","volume":"20","author":"Stovring","year":"2013","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.amjmed.2019.11.015_bib0021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jech.2005.041251","article-title":"Effectiveness calculation in economic analysis: the case of statins for cardiovascular disease prevention","volume":"60","author":"Franco","year":"2006","journal-title":"J Epidemiol Community Health"},{"issue":"9","key":"10.1016\/j.amjmed.2019.11.015_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007118","article-title":"The effect of statins on average survival in randomised trials, an analysis of end point postponement","volume":"5","author":"Kristensen","year":"2015","journal-title":"BMJ Open."},{"issue":"23","key":"10.1016\/j.amjmed.2019.11.015_bib0023","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1056\/NEJMc1509753","article-title":"Estimating the long-term treatment benefits of sacubitril\u2013valsartan","volume":"373","author":"Claggett","year":"2015","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.amjmed.2019.11.015_bib0024","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJM200105313442202","article-title":"A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure","volume":"344","author":"Eichhorn","year":"2001","journal-title":"N Engl J Med"},{"issue":"9146","key":"10.1016\/j.amjmed.2019.11.015_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"9169","key":"10.1016\/j.amjmed.2019.11.015_bib0026","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in-congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"8875","key":"10.1016\/j.amjmed.2019.11.015_bib0027","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","author":"Julian","year":"1993","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.amjmed.2019.11.015_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"Yusuf","year":"1991","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.amjmed.2019.11.015_bib0029","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting\u2013enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2019.11.015_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/eurheartj\/ehi021","article-title":"The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years","volume":"26","author":"Buch","year":"2005","journal-title":"Eur Heart J"},{"issue":"9386","key":"10.1016\/j.amjmed.2019.11.015_bib0031","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.amjmed.2019.11.015_bib0032","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2019.11.015_bib0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.amjmed.2019.11.015_bib0034","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.amjmed.2019.11.015_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."},{"issue":"9641","key":"10.1016\/j.amjmed.2019.11.015_bib0036","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"9744","key":"10.1016\/j.amjmed.2019.11.015_bib0037","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial","volume":"376","author":"B\u00f6hm","year":"2010","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.amjmed.2019.11.015_bib0038","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319310915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319310915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:21:14Z","timestamp":1757582474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319310915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0002934319310915"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.11.015","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}